by Plus Therapeutics | Dec 19, 2024 | GBM
🎗️ Now Streaming: ReSPECT-GBM Patient Story – Jim’s Journey as a Recurrent Glioblastoma Survivor Watch Jim’s Inspiring Story Now on YouTube: Watch Jim’s Story Dr. Jim Stockand, a dedicated educator with a PhD in Physiology, has devoted the past 24 years to...
by Plus Therapeutics | Dec 18, 2024 | GBM
❗NEW CLINICAL TRIAL SITE NOW ENROLLING PATIENTS: ReSPECT-GBM at North Shore University Hospital❗ We are excited to announce a new clinical trial investigation site for the ReSPECT-GBM clinical trial: North Shore University Hospital @NorthwellHealth in New York. Under...
by Plus Therapeutics | Dec 17, 2024 | LM
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data at 2024 San Antonio Breast Cancer Symposium (SABCS) ICYMI: Plus Therapeutics presented our ReSPECT-LM Phase 1 interim data for Breast Cancer patients with Leptomeningeal Metastases at the 2024 San...
by Plus Therapeutics | Dec 16, 2024 | GBM
COMING SOON: A Glioblastoma Survivor’s Journey with ReSPECT-GBM This week, we are thrilled to share a BRAND NEW patient testimonial from Jim, a courageous individual who has been navigating the challenges of recurrent glioblastoma. In this powerful video, Jim...
by Plus Therapeutics | Dec 11, 2024 | LM
Reminder: Visit Plus Therapeutics at #SABCS2024 in San Antonio – Booth #1542! Join us at #SABCS2024 in San Antonio, Texas, where Plus Therapeutics will be showcasing its groundbreaking work in targeted radiation therapy for central nervous system cancers including...
Recent Comments